The HSD3B7 antibody is a tool used to detect 3β-hydroxysteroid dehydrogenase type 7 (HSD3B7), an enzyme critical in bile acid biosynthesis. HSD3B7 catalyzes the oxidation and isomerization of 7α-hydroxy-cholest-4-en-3-one to 7α-hydroxy-3-oxocholest-4-en-26-oic acid, a key step in the classical pathway of bile acid synthesis. Mutations in the HSD3B7 gene cause congenital bile acid synthesis defects, leading to severe liver disorders, cholestasis, and fat-soluble vitamin deficiencies. The antibody is primarily utilized in research to study HSD3B7 expression, localization, and regulatory mechanisms in hepatic tissues and other relevant systems. It is employed in techniques like Western blotting, immunohistochemistry, and immunofluorescence to assess protein levels in disease models, such as cholestatic liver diseases or metabolic disorders. Commercially available HSD3B7 antibodies are typically developed in rabbits or mice using synthetic peptides or recombinant protein fragments as immunogens. Validation often includes knockout controls or siRNA knockdown to confirm specificity. Recent studies also explore its role in cancer metabolism and lipid homeostasis, expanding its relevance beyond hepatology. Proper handling requires attention to tissue-specific post-translational modifications that may affect antibody binding. This tool aids in elucidating molecular pathways of bile acid metabolism and developing therapeutic strategies for related disorders.